Anti-obesity drug discovery: advances and challenges | Nature Reviews Drug Discovery
A Royal Reception for Obesity Research - ConscienHealth
Novo Nordisk AS Medical Pipeline Products - GlobalData
Why Is Novo Nordisk Losing Its Steam And Is It Sustainable Or Not? (NYSE:NVO) | Seeking Alpha
Life-changing careers - Check out this open position at Novo Nordisk
Novo Nordisk: This Winner Has Risks, Be Aware (NYSE:NVO) | Seeking Alpha
Novo Nordisk adds to diabetes pipeline with Evotec deal | Fierce Biotech
Drug pipeline 1Q20 | Nature Biotechnology
ESC 365 - Novo Nordisk A/S
Can Novo Nordisk's pipeline transform obesity treatment? | pharmaphorum
Life-changing careers - Check out this open position at Novo Nordisk
Novo Nordisk's Innovative Research and Development Pipeline
Has the pipe run dry for Novo Nordisk? :: Scrip
Novo Nordisk Explores $800 Million Ziylo Acquisition to Build Insulin Pipeline - Xtalks
R&D pipeline
Pipeline - Forma Therapeutics
Novo Nordisk: Continuing The Growth, But Stock May Have Gotten Ahead Of Itself (NYSE:NVO) | Seeking Alpha
Alzheimer's Pipeline Grows with Novo Nordisk Investigating the Diabetes Link—The Implications are Big
